| US 7,468,186 B2 | ||
| Polyomavirus cellular epitopes and uses therefor | ||
| Simon F. Lacey, Glendora, Calif. (US) | ||
| Assigned to City of Hope, Duarte, Calif. (US) | ||
| Filed on Jul. 24, 2006, as Appl. No. 11/491,542. | ||
| Claims priority of provisional application 60/701484, filed on Jul. 22, 2005. | ||
| Prior Publication US 2007/0026503 A1, Feb. 01, 2007 | ||
| Int. Cl. A61K 39/12 (2006.01) | ||
| U.S. Cl. 424—204.1 [530/300] | 15 Claims |
| 1. A vaccine which comprises an isolated polyomavirus epitope peptide, wherein said peptide is selected from the group consisting of LLMWEAVTV (SEQ ID NO:1); NLLMWEAVTV (SEQ ID NO:2); and AITEVECEL (SEQ ID NO:5). |